- Home
- TRSG vs ABVC Comparison
TRSG vs ABVC Comparison
Compare TRSG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- ABVC
- Stock Information
- Founded
- TRSG 1996
- ABVC 2015
- Country
- TRSG Singapore
- ABVC United States
- Employees
- TRSG N/A
- ABVC N/A
- Industry
- TRSG
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- ABVC Health Care
- Exchange
- TRSG NYSE
- ABVC Nasdaq
- Market Cap
- TRSG 25.8M
- ABVC 22.1M
- IPO Year
- TRSG 2024
- ABVC N/A
- Fundamental
- Price
- TRSG $1.63
- ABVC $2.44
- Analyst Decision
- TRSG
- ABVC
- Analyst Count
- TRSG 0
- ABVC 0
- Target Price
- TRSG N/A
- ABVC N/A
- AVG Volume (30 Days)
- TRSG 8.2K
- ABVC 312.1K
- Earning Date
- TRSG 05-14-2025
- ABVC 08-13-2025
- Dividend Yield
- TRSG N/A
- ABVC N/A
- EPS Growth
- TRSG N/A
- ABVC N/A
- EPS
- TRSG N/A
- ABVC N/A
- Revenue
- TRSG $12,810,249.00
- ABVC $508,383.00
- Revenue This Year
- TRSG N/A
- ABVC $735.18
- Revenue Next Year
- TRSG N/A
- ABVC N/A
- P/E Ratio
- TRSG N/A
- ABVC N/A
- Revenue Growth
- TRSG N/A
- ABVC 1904.43
- 52 Week Low
- TRSG $1.00
- ABVC $0.40
- 52 Week High
- TRSG $4.57
- ABVC $2.29
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- ABVC 70.75
- Support Level
- TRSG N/A
- ABVC $1.84
- Resistance Level
- TRSG N/A
- ABVC $2.29
- Average True Range (ATR)
- TRSG 0.00
- ABVC 0.16
- MACD
- TRSG 0.00
- ABVC 0.03
- Stochastic Oscillator
- TRSG 0.00
- ABVC 87.65
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.